Skin appearance and injury repair need different evidence.
“Skin repair” can cover an awful lot of ground. I find claims easier to follow when I put the measurements next to each other. Some are answering entirely different questions.
What did the researchers measure?
The outcome is simply the thing a study measures. It might be a wrinkle, copper in a skin sample or the strength of a tendon. The setting matters just as much as the result.
| Study | What it can tell us |
|---|---|
| Small GHK-Cu cream studies | A review reports changes in skin appearance with particular creams. It doesn't test injections. |
| Copper in donated human skin | Copper entered and stayed in lab skin samples. That isn't a visible skin change. |
| Cut rat Achilles tendons | Rat tendons had better healing measures. Human injury recovery remains a separate question. |
| BPC-157 safety study in two adults | No side effects were observed in those two people. That can't establish broad safety. |
GLOW doesn't get a row of its own here because there isn't a controlled human blend trial to compare. Adding the ingredient studies together wouldn't create one.
What does the result leave unanswered?
Satisfaction and measurements can disagree
In a small study after laser skin treatment, people using copper-peptide skincare reported greater satisfaction. The measured redness and wrinkle results weren't significantly different. I find that contrast useful: the two kinds of result don't have to agree.
It was one small trial on freshly treated skin. It doesn't settle what every copper-peptide cream will do. It also isn't evidence about an injection.
Delivery can complicate the picture too. The review of GHK wrinkle research discusses the difficulty of getting the ingredient through skin. An ingredient list can't answer that delivery question.
The missing answers matter, too.
A result has edges
A skin-appearance study may tell little about tissue strength. A short study can't settle long-term safety. And a small study can miss uncommon harms, even if nobody reports a problem.
The review of BPC-157 healing research leaves major gaps in human evidence. The wider peptide review also describes scarce rigorous safety data. Those gaps matter when a claim starts to sound like a dependable treatment.
For a personal health decision, a licensed U.S. clinician can discuss evidence for the concern you actually have. These comparisons are here to help you read a claim. They can't choose a treatment for you.